Inspire Medical Systems Files 8-K on Operations & Financial Condition

Ticker: INSP · Form: 8-K · Filed: Jan 8, 2024 · CIK: 1609550

Inspire Medical Systems, INC. 8-K Filing Summary
FieldDetail
CompanyInspire Medical Systems, INC. (INSP)
Form Type8-K
Filed DateJan 8, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: financial-condition, regulation-fd, corporate-governance

TL;DR

**Inspire Medical Systems just dropped an 8-K, new financial info coming!**

AI Summary

Inspire Medical Systems, Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition, as well as Regulation FD disclosure. This filing indicates that the company is providing current information to the market, likely ahead of a public announcement or investor event. For investors, this matters because it signals that new financial information or operational updates are being made available, which could influence the stock's valuation and future performance.

Why It Matters

This filing indicates that Inspire Medical Systems is making new financial and operational information public, which could impact investor sentiment and stock price. Investors should look for the specific details of these disclosures to understand the company's current health and future prospects.

Risk Assessment

Risk Level: low — This 8-K is a procedural filing to disclose information, not an event that inherently carries high risk.

Analyst Insight

A smart investor would look for the specific content of the 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure' that this 8-K refers to, as this filing is merely a notification that such information has been or will be made public. This filing itself doesn't contain the detailed financial data.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Inspire Medical Systems, Inc.?

The primary purpose of this 8-K filing, dated January 8, 2024, is to report on 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure' as per Item Information.

What is the trading symbol and the exchange where Inspire Medical Systems, Inc. common stock is registered?

The trading symbol for Inspire Medical Systems, Inc. Common Stock is INSP, and it is registered on the New York Stock Exchange.

Where are the principal executive offices of Inspire Medical Systems, Inc. located?

The principal executive offices of Inspire Medical Systems, Inc. are located at 5500 Wayzata Blvd., Suite 1600, Golden Valley, Minnesota 55416.

What is the state of incorporation for Inspire Medical Systems, Inc.?

Inspire Medical Systems, Inc. is incorporated in Delaware.

What is the earliest event reported date in this 8-K filing?

The date of the earliest event reported in this 8-K filing is January 8, 2024.

Filing Stats: 640 words · 3 min read · ~2 pages · Grade level 9.3 · Accepted 2024-01-08 08:03:23

Key Financial Figures

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On January 8, 2024, Inspire Medical Systems, Inc. (the "Company") issued a press release announcing certain preliminary and unaudited results for the quarter and full year ended December 31, 2023. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. In January of 2024, the Company will be participating in various meetings with investors and analysts, and a copy of the Company's presentation materials being used at these meetings is furnished as Exhibit 99.2 hereto and is incorporated herein by reference. These presentation materials are also available on the Investor Relations page of the Company's website at https://investors.inspiresleep.com. The information in each of Item 2.02 and Item 7.01 of this Current Report on Form 8-K and in the press release attached as Exhibit 99.1 and the presentation attached as Exhibit 99.2 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of Inspire Medical Systems, Inc., dated January 8 , 202 4 . 99.2 Inspire Medical Systems, Inc. Presentation, January 2024 . 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIRE MEDICAL SYSTEMS, INC. Date: January 8, 2024 By: /s/ Richard J. Buchholz Richard J. Buchholz Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing